$46.24
0.060.13%
At close: -
$46.25
0.010000.02%
After Hours: 4:03 PM EDT
Comments
Loading...
SpringWorks Therapeutics Insider Trading Activity | NASDAQ:SWTX | Benzinga
Track the latest SpringWorks Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for SpringWorks Therapeutics stock.
What is Insider Activity?
Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.
What are SpringWorks Therapeutics Inc Insiders Doing?
Insiders have report no purchases/sales in the last 30 days.
Notable Recent Insider Buys and Sales
- On February 19, 2025, DANIEL LYNCH, the company's DIRECTOR sold 400 shares for $60 each.
- On February 24, 2025, Bhavesh Ashar, the company's CHIEF COMMERCIAL OFFICER sold 1.02K shares for $61.19 each.
- On February 19, 2025, Saqib Islam, the company's CHIEF EXECUTIVE OFFICER sold 10.67K shares for $59.92 each.
Ownership Statistics for SpringWorks Therapeutics Inc
Shares Outstanding
74.936M
Insider Shares Owned
2.505M
Insider Percentage Owned
3.34%
Institutional Shares Held
50.032M
Institutional Percentage Held
66.7%
| Mar 05, 2025 | Badreddin Edris | CHIEF OPERATING OFFICER | -20.00K | $54.23 | -$1.08M | SELL | -10.54% | 169.71K | Mar 03 | View |
| Mar 05, 2025 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -79.76K | $53.92 | -$4.30M | SELL | -7.71% | 954.87K | Feb 27 - Mar 03 | View |
| Feb 24, 2025 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -29.33K | $60.30 | -$1.77M | SELL | -2.76% | 1.03M | Feb 20 | View |
| Feb 24, 2025 | Bhavesh Ashar | CHIEF COMMERCIAL OFFICER | -1.02K | $61.19 | -$62.17K | SELL | -1.61% | 62.05K | Feb 20 | View |
| Feb 24, 2025 | DANIEL LYNCH | DIRECTOR | -47.60K | $60.22 | -$2.87M | SELL | -36.46% | 82.94K | Feb 20 | View |
| Feb 19, 2025 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -10.67K | $59.92 | -$639.49K | SELL | -0.99% | 1.06M | Feb 14 | View |
| Feb 19, 2025 | DANIEL LYNCH | DIRECTOR | -400.00 | $60.00 | -$24.00K | SELL | -0.31% | 130.54K | Feb 14 | View |
| Feb 12, 2025 | Daniel Pichl | CHIEF PEOPLE OFFICER | 0.00 | $41.00 | -$795.04K | SELL-OPTIONS | 0.00% | 50.76K | Feb 10 | View |
| Feb 12, 2025 | DANIEL LYNCH | DIRECTOR | -175.00K | $54.46 | -$9.53M | SELL | -57.20% | 130.94K | Feb 10 | View |
| Feb 12, 2025 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -48.00K | $53.30 | -$2.56M | SELL | -4.57% | 1.00M | Feb 10 | View |
| Feb 12, 2025 | Julie Hambleton | DIRECTOR | 0.00 | $42.64 | -$285.72K | SELL-OPTIONS | 0.00% | 4.09K | Feb 10 | View |
| Feb 12, 2025 | Badreddin Edris | CHIEF OPERATING OFFICER | -30.00K | $53.13 | -$1.59M | SELL | -13.65% | 189.71K | Feb 10 | View |
| Dec 05, 2024 | Badreddin Edris | CHIEF OPERATING OFFICER | -20.00K | $41.97 | -$839.34K | SELL | -8.71% | 209.60K | Dec 03 | View |
| Dec 04, 2024 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -49.00K | $41.37 | -$2.03M | SELL | -4.61% | 1.01M | Dec 02 | View |
| Sep 04, 2024 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -49.00K | $40.57 | -$1.99M | SELL | -4.41% | 1.06M | Sep 03 | View |
| Sep 04, 2024 | Badreddin Edris | CHIEF OPERATING OFFICER | -20.00K | $40.65 | -$812.95K | SELL | -8.01% | 229.60K | Sep 03 | View |
| Jun 05, 2024 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -49.00K | $39.90 | -$1.96M | SELL | -4.22% | 1.11M | Jun 03 | View |
| Jun 05, 2024 | Julie Hambleton | DIRECTOR | -4.65K | $40.03 | -$186.05K | SELL | -53.16% | 4.09K | Jun 03 | View |
| Jun 05, 2024 | Badreddin Edris | CHIEF OPERATING OFFICER | -20.00K | $40.07 | -$801.37K | SELL | -7.42% | 249.60K | Jun 03 | View |
| Feb 20, 2024 | Daniel Pichl | CHIEF PEOPLE OFFICER | 0.00 | $38.87 | -$336.95K | SELL-OPTIONS | 0.00% | 45.21K | Feb 16 | View |
| Feb 05, 2024 | Bhavesh Ashar | CHIEF COMMERCIAL OFFICER | -8.06K | $47.34 | -$381.41K | SELL | -12.17% | 58.15K | Feb 02 - Feb 05 | View |
| Feb 05, 2024 | Daniel Pichl | CHIEF PEOPLE OFFICER | -9.93K | $35.98 | -$711.21K | SELL | -18.01% | 45.21K | Feb 02 | View |
| Jul 21, 2023 | Julie Hambleton | DIRECTOR | -2.42K | $29.31 | -$70.88K | SELL | -34.22% | 4.65K | Jul 19 | View |
| Jun 22, 2023 | Julie Hambleton | DIRECTOR | -2.40K | $26.92 | -$64.60K | SELL | -25.35% | 7.07K | Jun 20 | View |
| Mar 20, 2023 | Jeffrey Schwartz | DIRECTOR | -1.75M | $28.50 | -$49.88M | SELL | -36.18% | 3.09M | Mar 16 | View |
| Mar 16, 2023 | Julie Hambleton | DIRECTOR | -1.11K | $31.50 | -$34.84K | SELL | -18.67% | 4.82K | Mar 15 | View |
| Jan 27, 2023 | Daniel Pichl | CHIEF PEOPLE OFFICER | -858.00 | $31.00 | -$26.60K | SELL | -2.38% | 35.20K | Jan 26 | View |
| Sep 14, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -153.90K | $31.96 | -$4.92M | SELL | -2.67% | 5.60M | Sep 12 | View |
| Aug 10, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -274.57K | $38.11 | -$10.46M | SELL | -4.55% | 5.75M | Aug 08 - Aug 09 | View |
| Oct 20, 2021 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -10.08K | $58.67 | -$591.53K | SELL | -1.28% | 779.22K | Oct 20 | View |
| Oct 19, 2021 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -52.42K | $58.65 | -$3.07M | SELL | -6.38% | 769.13K | Oct 18 - Oct 19 | View |
| Oct 13, 2021 | Mary Smith | CHIEF DEVELOPMENT OFFICER | 0.00 | $29.13 | -$536.67K | SELL-OPTIONS | 0.00% | 167.51K | Oct 13 | View |
| Aug 12, 2021 | Bain Capital Life Sciences Investors LLCBC SW LPLawrence Jeffrey SchwartzAdam Koppel | DIRECTOR | -1.00M | $70.25 | -$70.25M | SELL | -17.15% | 4.83M | Aug 10 | View |
| Jul 20, 2021 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -62.50K | $76.56 | -$4.79M | SELL | -7.07% | 821.55K | Jul 19 - Jul 20 | View |
| Jul 14, 2021 | Mary Smith | CHIEF DEVELOPMENT OFFICER | 0.00 | $41.59 | -$785.78K | SELL-OPTIONS | 0.00% | 167.51K | Jul 13 | View |
| Jul 06, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -15.96K | $85.01 | -$1.36M | SELL | -0.26% | 6.03M | Jul 01 | View |
| Jul 01, 2021 | Badreddin Edris | CHIEF OPERATING OFFICER | -32.00K | $85.35 | -$2.73M | SELL | -9.59% | 301.54K | Jul 01 | View |
| Jun 30, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -6.50K | $85.17 | -$553.78K | SELL | -0.11% | 6.04M | Jun 28 | View |
| Jun 25, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -56.63K | $85.19 | -$4.82M | SELL | -0.93% | 6.05M | Jun 23 - Jun 25 | View |
| Jun 14, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -30.85K | $85.09 | -$2.63M | SELL | -0.50% | 6.11M | Jun 10 | View |
| Jun 09, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -48.05K | $85.36 | -$4.10M | SELL | -0.78% | 6.14M | Jun 07 - Jun 09 | View |
| Apr 28, 2021 | STEPHEN SQUINTO | DIRECTOR | -19.43K | $76.19 | -$1.48M | SELL | -13.39% | 125.73K | Apr 27 - Apr 28 | View |
| Apr 20, 2021 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -62.50K | $68.02 | -$4.25M | SELL | -6.60% | 884.05K | Apr 19 - Apr 20 | View |
| Apr 19, 2021 | STEPHEN SQUINTO | DIRECTOR | -1.57K | $75.04 | -$117.66K | SELL | -1.07% | 145.16K | Apr 14 - Apr 15 | View |
| Apr 13, 2021 | Mary Smith | CHIEF DEVELOPMENT OFFICER | 0.00 | $35.19 | -$657.72K | SELL-OPTIONS | 0.00% | 167.51K | Apr 13 | View |
| Mar 11, 2021 | Bain Capital Life Sciences Investors LLCBC SW LPLawrence Jeffrey SchwartzAdam Koppel | DIRECTOR | -1.45M | $71.50 | -$103.67M | SELL | -19.91% | 5.83M | Mar 09 | View |
| Mar 03, 2021 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLC | 10% OWNER | -1.22M | $83.19 | -$101.49M | SELL | -16.47% | 6.19M | Mar 01 | View |
| Jan 26, 2021 | Badreddin Edris | CHIEF OPERATING OFFICER | -32.00K | $84.07 | -$2.69M | SELL | -10.90% | 261.54K | Jan 25 | View |
| Jan 21, 2021 | Mary Smith | CHIEF DEVELOPMENT OFFICER | 0.00 | $40.46 | -$764.75K | SELL-OPTIONS | 0.00% | 167.51K | Jan 20 | View |
| Jan 21, 2021 | Saqib Islam | CHIEF EXECUTIVE OFFICER | -62.50K | $78.55 | -$4.91M | SELL | -4.86% | 1.22M | Jan 19 - Jan 20 | View |
FAQ
Is insider trading legal?
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
What are some examples of market manipulation?
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.
Browse insider trades on all stocks.
